CALT - Calliditas Therapeutics launches online patient platform
Calliditas Therapeutics (NASDAQ:CALT) announces the launch of IgAN Connect, a new online platform to provide resources to people living with IgA nephropathy, or IgAN, a chronic autoimmune disease. IgANConnect.com provides individuals diagnosed with IgA nephropathy and caregivers the tools to help understand and manage IgA nephropathy. The complimentary IgAN Connect Facebook page provides an environment where individuals living with the disease are encouraged to explore educational and motivational resources alongside other members of the community, the company said.
For further details see:
Calliditas Therapeutics launches online patient platform